Presentation of the Patient Advisory Board at our 2nd annual meeting in November
The K.G. Jebsen Colorectal Cancer Research Centre is proud to present our recently appointed Patient Advisory Board. The board members have own experience with the colorectal cancer disease or are next of kin.
Patient Advisory Board
At the 2nd annual meeting in our Centre held at the Grand Hotel in Oslo on the 10th of November 2016, the recently appointed Patient Advisory Board was formally presented. The board members’ experience and opinions will contribute in the design, conduct and evaluation of ongoing and new projects. The members will give valuable input when designing easily understandable information to patients before inclusion in a project and advice to researchers in difficult ethical aspects related to the projects.
The Centre PIs are grateful to the board members for their willingness to share experiences and opinions related to colorectal cancer and research topics, and we believe this initiative will be beneficial to all parties involved. User involvement in clinical research is a pronounced strategy from the Norwegian health authorities and from our hospital.
Latest publicationsBrunsell et al. 2019. High concordance and negative prognostic impact of RAS/BRAF/PIK3CA mutations in multiple resected colorectal liver metastases. Clin. Colorectal Cancer [Online ahead of print] Sveen et al. 2019. Predictive modeling in colorectal cancer: time to move beyond consensus molecular subtypes. Ann. Oncol. 30(11): 1682-1685 Miranda et al. 2019. Cancer stemness, intratumoral heterogeneity, and immune response across cancers. PNAS 116(18): 9020-9029 Burocziova et al. 2019. Truncated PPM1D impairs stem cell response to genotoxic stress and promotes growth of APC-deficient tumors in the mouse colon. Cell Death. Dis. 10(11): 818
Eilertsen et al. 2019. Technical differences between sequencing and microarray platforms impact transcriptomic subtyping of colorectal cancer. Cancer Lett. [Epub ahead of print] All publications